ExesaLibero Pharma, in partnership with Redwire Space, launched the precursors of ELP-004 to the International Space Station

10/23/2024

The precursors of ELP-004 were launched to the ISS aboard SpX31. Special instrumentation provided by Redwire allowed the synthesis of ELP-004 on the ISS to determine if the drug synthesis was altered due to microgravity. The product was recovered and is undergoing analysis at WVU.